Stéphanie Cornen

Natural killer cell therapies

Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli et al. · Nature · 2024 · 419 citations · Full text

Life Sciences, Immunology, Innate Immunity +6

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

Olivier Demaria, Laurent Gauthier, Marie Vétizou et al. · Cell Reports Medicine · 2022 · 68 citations · Full text

Life Sciences, Immunology, Oncology +17

Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling

Stéphanie Cornen, Arnaud Guillé, José Adélaı̈de et al. · PLoS ONE · 2014 · 62 citations · Full text

Medicine, Genetics, Oncology +17

123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial

Dimitrios Colevas, Krzysztof Misiukiewicz, Alexander T. Pearson et al. · Annals of Oncology · 2021 · 12 citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Abstract 2713: Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy

Olivier Bénac, Marion Gaudin, Mélody Ors et al. · Cancer Research · 2018 · 10 citations

Life Sciences, Immunology, Oncology +17